Published in J Pediatr Hematol Oncol on May 01, 2014
Telomere diseases. N Engl J Med (2009) 5.68
Cancer in dyskeratosis congenita. Blood (2009) 4.28
Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr (1997) 3.80
Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration. Arthritis Rheum (2010) 2.29
Dyskeratosis congenita. Hematology Am Soc Hematol Educ Program (2011) 2.21
Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology (2012) 1.91
A spectrum of severe familial liver disorders associate with telomerase mutations. PLoS One (2009) 1.57
The genetics of dyskeratosis congenita. Cancer Genet (2011) 1.50
Pediatric hepatic angiosarcoma: case report and review of the literature. Pediatr Dev Pathol (2004) 1.49
Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita. Am J Hum Genet (1997) 1.25
Dyskeratosis congenita: a combined immunodeficiency with broad clinical spectrum--a single-center pediatric experience. Pediatr Allergy Immunol (2011) 1.23
Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome). Eur J Pediatr (2003) 1.11
Vascular tumors in children and adolescents: a clinicopathologic study of 228 tumors in 222 patients. Pathol Annu (1993) 1.04
Splenic peliosis and rupture in patients with dyskeratosis congenita on androgens and granulocyte colony-stimulating factor. Br J Haematol (2007) 1.00
Infliximab for Crohn's disease: the first 500 patients followed up through 2009. Dig Dis Sci (2012) 0.92
Hemangiosarcoma of the liver. Spectrum of morphologic changes and clinical findings. Mayo Clin Proc (1975) 0.91
Gastrointestinal involvement in a woman with dyskeratosis congenita. Dig Dis Sci (1993) 0.88
A case of dyskeratosis congenita with portal hypertension associated with jugular venous anomaly. Turk J Gastroenterol (2006) 0.86
Angiosarcoma in a patient with immunodeficiency, centromeric region instability, facial anomalies (ICF) syndrome. Am J Med Genet A (2011) 0.86
Angiosarcomas arising in the viscera and soft tissue of children and young adults: a clinicopathologic study of 15 cases. Am J Surg Pathol (2009) 0.84
Dyskeratosis congenita with portal hypertension of unknown etiology. J Assoc Physicians India (2011) 0.81
Kaposi's sarcoma associated with tumour necrosis factor alpha neutralising therapy. Ann Rheum Dis (2003) 0.81
Cyanosis revealing hepatopulmonary syndrome in a child with dyskeratosis congenita. Pediatr Pulmonol (2010) 0.80
Sarcomas other than Kaposi sarcoma occurring in immunodeficiency: interpretations from a systematic literature review. Curr Opin Oncol (2012) 0.79
Dyskeratosis congenita--report of a case with emphasis on gingival aspects. Pediatr Dermatol (2009) 0.78
Kaposi's sarcoma presenting as a protracted multisystem illness in an adolescent liver transplant recipient. Liver Transpl Surg (1997) 0.77
Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol (2008) 4.41
Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood (2005) 3.71
ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature (2006) 3.35
Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet (2007) 2.79
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood (2007) 2.76
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood (2007) 2.36
Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Proc Natl Acad Sci U S A (2004) 2.01
Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study. J Clin Oncol (2010) 2.00
TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood (2008) 1.99
Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore) (2011) 1.96
3'UTR-truncated Hmga2 cDNA causes MPN-like hematopoiesis by conferring a clonal growth advantage at the level of HSC in mice. Blood (2011) 1.96
Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients. Blood (2013) 1.82
Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N Engl J Med (2014) 1.81
The role of human ribosomal proteins in the maturation of rRNA and ribosome production. RNA (2008) 1.81
Pediatric common variable immunodeficiency: immunologic and phenotypic associations with switched memory B cells. Pediatr Allergy Immunol (2010) 1.69
Cells depleted for RPS19, a protein associated with Diamond Blackfan Anemia, show defects in 18S ribosomal RNA synthesis and small ribosomal subunit production. Blood Cells Mol Dis (2007) 1.68
Progressive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatment. Clin Immunol (2002) 1.64
Genome-wide association identifies diverse causes of common variable immunodeficiency. J Allergy Clin Immunol (2011) 1.60
Mutations of the SBDS gene are present in most patients with Shwachman-Diamond syndrome. Blood (2004) 1.58
The effect of TERC haploinsufficiency on the inheritance of telomere length. Proc Natl Acad Sci U S A (2005) 1.56
The genetics of dyskeratosis congenita. Cancer Genet (2011) 1.50
How to flee the flu. Clin Immunol (2004) 1.40
A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice. Proc Natl Acad Sci U S A (2008) 1.37
Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol (2010) 1.35
Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita. Blood (2004) 1.33
Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DS. J Med Genet (2012) 1.33
Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS). Blood (2004) 1.32
Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice. Oncogene (2002) 1.31
Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS). Blood (2006) 1.31
Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol (2013) 1.31
Histone acetylation and chromatin conformation are regulated separately at the TNF-alpha promoter in monocytes and macrophages. J Leukoc Biol (2003) 1.28
Immune dysregulation in severe influenza. J Leukoc Biol (2009) 1.27
Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene. Blood (2007) 1.26
Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. J Allergy Clin Immunol (2008) 1.25
Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome. Br J Haematol (2009) 1.20
Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome. J Pediatr Hematol Oncol (2006) 1.15
Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. N Engl J Med (2015) 1.10
Genetics and epigenetics of systemic lupus erythematosus. Curr Rheumatol Rep (2013) 1.08
GCF2/LRRFIP1 represses tumor necrosis factor alpha expression. Mol Cell Biol (2005) 1.07
A role for PKC-delta and PI 3-kinase in TNF-alpha-mediated antiapoptotic signaling in the human neutrophil. Am J Physiol Cell Physiol (2002) 1.06
Telomerase reverse transcriptase haploinsufficiency and telomere length in individuals with 5p- syndrome. Aging Cell (2007) 1.05
A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal Haemoglobinuria. BMC Blood Disord (2004) 1.05
T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome. Blood (2003) 1.04
Infections in patients with inherited defects in phagocytic function. Clin Microbiol Rev (2003) 1.02
Autoimmunity and inflammation in X-linked agammaglobulinemia. J Clin Immunol (2014) 1.01
Dyskerin ablation in mouse liver inhibits rRNA processing and cell division. Mol Cell Biol (2009) 1.01
Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes). Curr Opin Pediatr (2002) 1.01
ScFv-mediated in vivo targeting of DAF to erythrocytes inhibits lysis by complement. Mol Immunol (2004) 1.00
Associations of tumor necrosis factor alpha and HLA polymorphisms with adult dermatomyositis: implications for a unique pathogenesis. J Invest Dermatol (2002) 1.00
Malignancy in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Am J Med Genet A (2006) 0.98
What's in a name? J Clin Invest (2012) 0.98
Clinical conditions associated with PCP in children. Pediatr Pulmonol (2011) 0.98
Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica (2014) 0.97
Polarization of primary human monocytes by IFN-gamma induces chromatin changes and recruits RNA Pol II to the TNF-alpha promoter. J Immunol (2008) 0.97
TINF2 mutations in children with severe aplastic anemia. Pediatr Blood Cancer (2009) 0.97
Genome-wide analysis of interferon regulatory factor I binding in primary human monocytes. Gene (2011) 0.96
Dyskerin, telomerase and the DNA damage response. Cell Cycle (2009) 0.96
Human telomerase RNA mutations and bone marrow failure. Lancet (2003) 0.96
Pulmonary effects of i.v. injection of crushed oral tablets: "excipient lung disease". AJR Am J Roentgenol (2014) 0.95
Thrombocytopenia in patients with chromosome 22q11.2 deletion syndrome. J Pediatr (2003) 0.95
Use of sirolimus in IPEX and IPEX-like children. J Clin Immunol (2008) 0.94
Rituximab-treated patients have a poor response to influenza vaccination. J Clin Immunol (2012) 0.92
Allergies in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) and patients with chronic granulomatous disease. Pediatr Allergy Immunol (2005) 0.92
Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Pediatrics (2003) 0.91
Clinical utility gene card for: dyskeratosis congenita. Eur J Hum Genet (2011) 0.91
Immune abnormalities are a frequent manifestation of Kabuki syndrome. Am J Med Genet A (2005) 0.90
Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. J Clin Invest (2015) 0.90
Chronic recurrent multifocal osteomyelitis. J Clin Immunol (2013) 0.90
Mannose binding lectin (MBL) polymorphisms associated with low MBL production in patients with dermatomyositis. J Invest Dermatol (2002) 0.89
Immunoglobulin deficiencies: the B-lymphocyte side of DiGeorge Syndrome. J Pediatr (2012) 0.89
LPS and poly I:C induce chromatin modifications at a novel upstream region of the IL-23 p19 promoter. Inflammation (2008) 0.89
Inherited bone marrow failure syndromes in adolescents and young adults. Ann Med (2014) 0.88
A label-free proteome analysis strategy for identifying quantitative changes in erythrocyte membranes induced by red cell disorders. J Proteomics (2012) 0.88
Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): an initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC). Pediatr Blood Cancer (2013) 0.88
Adoptive transfer of autologous T cells improves T-cell repertoire diversity and long-term B-cell function in pediatric patients with neuroblastoma. Clin Cancer Res (2012) 0.88
CD68 expression is markedly different in Crohn's disease and the colitis associated with chronic granulomatous disease. Inflamm Bowel Dis (2009) 0.88
Recent insights into inherited bone marrow failure syndromes. Curr Opin Pediatr (2012) 0.88
Contiguous X-chromosome deletion syndrome encompassing the BTK, TIMM8A, TAF7L, and DRP2 genes. J Clin Immunol (2007) 0.87
Accelerated hematopoietic stem cell aging in a mouse model of dyskeratosis congenita responds to antioxidant treatment. Aging Cell (2011) 0.87
Anomalous electrophoretic migration of newly synthesized ribosomal RNAs and their precursors from cells with DKC1 mutations. FEBS Lett (2009) 0.87
The efficacy of influenza vaccination in a pediatric oncology population. J Pediatr Hematol Oncol (2010) 0.87
Characterization of LRRFIP1. Biochem Cell Biol (2010) 0.87
A potential screening tool for IPEX syndrome. Pediatr Dev Pathol (2007) 0.86
Dysfunctional telomeres and dyskeratosis congenita. Haematologica (2007) 0.86
Acquired aplastic anemia in children. Pediatr Clin North Am (2013) 0.86
Bone marrow failure in Shwachman-Diamond syndrome does not select for clonal haematopoiesis of the paroxysmal nocturnal haemoglobinuria phenotype. Br J Haematol (2002) 0.86
A four base pair insertion in exon 1 of the RPS19 gene is a common polymorphism in African-Americans. Br J Haematol (2006) 0.85
Myeloid differentiation primary response gene 88 (MyD88) deficiency in a large kindred. J Allergy Clin Immunol (2010) 0.85
Interferon regulatory factor 1 marks activated genes and can induce target gene expression in systemic lupus erythematosus. Arthritis Rheumatol (2015) 0.84
Systemic conditions associated with periodontitis in childhood and adolescence. A review of diagnostic possibilities. Med Oral Patol Oral Cir Bucal (2005) 0.83
Single nucleotide polymorphism array analysis of bone marrow failure patients reveals characteristic patterns of genetic changes. Br J Haematol (2013) 0.83
TNFalpha inhibition in MRL/lpr mice ameliorates pulmonary but not renal disease. J Autoimmun (2002) 0.83
Leucine-rich repeat (in Flightless I) interacting protein-1 regulates a rapid type I interferon response. J Interferon Cytokine Res (2010) 0.83
TH1 and TH2 cytokine mRNA and protein levels in human immunodeficiency virus (HIV)-seropositive and HIV-seronegative youths. Clin Diagn Lab Immunol (2003) 0.82
Cytokine-induced monocyte characteristics in SLE. J Biomed Biotechnol (2010) 0.82
Immunologic consequences of chemotherapy for acute myeloid leukemia. J Pediatr Hematol Oncol (2013) 0.82
Age-related trends in pediatric B-cell subsets. Pediatr Dev Pathol (2010) 0.82